Value Hunters: Look To Cytokinetics Inc (CYTK)
BlackRock Fund Advisors recently announced the acquisition of new stake in Cytokinetics Inc (NASDAQ:CYTK). The institutional investor has increased its shareholding in the Healthcare company by 0.15% to 14.19 million shares with purchase of 21755.0 shares. This fresh investment now brings its stake to 14.47% valued currently at $475.17 million. In addition, The Vanguard Group, […]
Cytokinetics Inc (NASDAQ: CYTK) – Not A Clear Buying Opportunity?
BlackRock Fund Advisors has recently announced that it has increased stake in Cytokinetics Inc (NASDAQ:CYTK) by 0.15%. After grabbing 14.19 million shares, the institutional investor is now in possession of 21755.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 14.47% having worth around $475.17 million. Moreover, The Vanguard […]
